Mean time to cancer-specific death of apparently clinically localised prostate cancer: policy implications for threshold ages in prostate-specific antigen and ablative therapy.
Kooiman
G G
GG
Muir
G
G
D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D011379:Prognosis; D017430:Prostate-Specific Antigen / Q000097:blood; D011471:Prostatic Neoplasms / Q000097:blood / Q000473:pathology / Q000628:therapy*; D020728:Transurethral Resection of Prostate / Q000379:methods
D017430:Prostate-Specific Antigen